FLAGSTAFF, Ariz., June 13, 2017 /PRNewswire/ -- SenesTech, Inc.
(NASDAQ: SNES), a developer of proprietary technologies for managing animal pest populations through fertility control, announced
today that in an effort to ensure that the Company can meet the rapidly increasing demand for their innovative new rodent control
technology, ContraPest, it has launched its second manufacturing line in Flagstaff. With the
addition of this second line, the Company's existing manufacturing capacity is expected to more than double.
"We continue to learn and improve, and have incorporated that knowledge into this second line. We are confident that we will
be able to handle the anticipated increase in demand," said Elissa Calloway, Vice President of
Manufacturing at SenesTech.
In order to utilize both manufacturing lines, SenesTech has added additional staff in both manufacturing and quality
control.
"Delighting our customers is our primary focus. Our increased capacity insures timely and uninterrupted delivery of
ContraPest," said Andrew Altman, Chief Operating Officer.
About SenesTech
SenesTech has developed an innovative technology for managing animal pest populations through fertility control as opposed to
a lethal approach.
The Company's first fertility control product, ContraPest®, is marketed for use in controlling rat infestations.
ContraPest's novel technology and approach targets the reproductive capabilities of both sexes, inducing egg loss in female
rodents and impairing sperm development in males. Using proprietary bait stations, ContraPest is dispensed in a highly
palatable liquid formulation that promotes sustained consumption by rodent communities. ContraPest is designed, formulated
and dispensed to be safe for handlers and non-target species such as wildlife, livestock and pets, in a biodegradable product. In
contrast, the historical approach to managing rodent pest populations, rodenticides, carries a high risk of environmental
contamination and the poisoning of non-target animals, pets and children.
We believe our non-lethal approach, targeting reproduction, is more humane, less harmful to the environment, and more
effective in providing a sustainable solution to pest infestations than traditional lethal pest management methods. There is
currently no other non-lethal fertility control product approved by the Food and Drug Administration (FDA), or the Environmental
Protection Agency (EPA), for the management of rodent populations. We believe ContraPest® will establish a
new paradigm in rodent control, resulting in improved performance in rodent control over rodenticides, without the negative
environmental effects of rodenticides. For more information visit the SenesTech website at www.senestech.com.
Safe Harbor Statement
This release contains "forward-looking statements" within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended and such
forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of
1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by
words such as "may," "future," "plan" or "planned," "will" or "should," "expected," "anticipates," "draft," "eventually" or
"projected." You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future
circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the
risks that actual results may differ materially from those projected in the forward-looking statements as a result of various
factors and other risks identified in our filings with the Securities and Exchange Commission. All forward-looking statements
contained in this press release speak only as of the date on which they were made and are based on management's assumptions and
estimates as of such date. We do not undertake any obligation to publicly update any forward-looking statements, whether as a
result of the receipt of new information, the occurrence of future events or otherwise.
CONTACT:
Investor: Robert Blum, Joe Dorame, Joe
Diaz, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc, 928-779-4143
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/senestech-launches-second-manufacturing-line-in-flagstaff-to-ensure-uninterrupted-demand-300472666.html
SOURCE SenesTech, Inc.